close
Add to watchlist
DUSA Pharmaceuticals, Inc (DUSA) Healthcare, Biotechnology & Drugs
DUSA Pharmaceuticals, Inc., an integrated dermatology pharmaceutical company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally. Its products include Levulan Kerastick 20% Topical Solution with PDT and the BLU-U brand light source for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp. The BLU-U is used without Levulan to treat moderate inflammatory acne vulgaris and general dermatological conditions. The company is also developing non-PDT drug products, including Nicomide, Nicomide-T, AVAR products, ClindaReach, Meted, and Psoriacap products. DUSA Pharmaceuticals, Inc. was founded in 1991 and is based in Wilmington, Massachusetts.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 5.79 |
| Volume | 213251 |
| Volume Avg | 156050 |
| 52 Week High | 6.83 |
| 52 Week Low | 3.25 |
| PE | 20.93 |
| PE (group average) | 39 |
| EPS Year | 0.28 |
| EPS change Q/Q | 1000% |
| EPS change Q/Q Yr ago | 0% |
| EPS change Q/Q next Q est | 1000% |
| EPS change Y/Y | 1000% |
| REV change Q/Q | -7.5% |
| REV change Q/Q Yr ago | 27.59% |
| EPS next Q est | 0.07 |
| EPS next Y est | 0.53 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |